O Berk pharma bottle is ready to ship

Published: 27-May-2010

HDPE Pharma Oblong in amber now available from stock

O Berk pharma bottle is ready to ship
O Berk Company, a US supplier and distributor of glass and plastic containers, closures, pumps and sprayers for the pharmaceutical and healthcare industries, is offering its 16oz HDPE Pharma Oblong bottle in amber from stock. The bottle is also available by special order in natural, white or a custom colour.

The 16oz Pharma Oblong is suitable for prescription and over-the-counter (OTC) liquid pharmaceutical products. There bottle is supplied with a variety of child-resistant and standard continuous threaded closures. The bottle surface has an indented panel that is easy to personalise.

Both bottles and closures are supported with data indicating US FDA compliance.

See more

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Analysis
Specifying synthetic peptides: why the impurity profile, not the purity figure, is the specification

Specifying synthetic peptides: why the impurity profile, not the purity figure, is the specification

Read more
A single HPLC percentage can’t tell two peptide lots apart. A specification that names impurity classes, sets individual limits and demands mass balance can

Trending Articles

  1. Loftware and RiseNow partner to strengthen supply chain traceability and compliance in healthcare settings The alliance pairs Loftware's SAP-integrated product identification platform with RiseNow's procurement and supply chain advisory services, delivering end-to-end track-and-trace capabilities for regulated industries where audit readiness and patient safety are critical
  2. Promega UK launches Lumit insulin immunoassay Wash-free assay enables rapid measurement of insulin secretion for metabolic disease drug discovery
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Protecting data quality in pharmaceutical supply chains The pharmaceutical industry is becoming more connected and automated with data-driven technologies helping to support operations with little to no human contact. As a result, data quality has become a key talking point!
  4. UK liquid manufacturing: why British production matters for healthcare and the economy How specialist liquid manufacturing in Newcastle supports UK healthcare supply chains, skilled employment and pharmaceutical and nutraceutical production Edited copy
  5. ScionxBio and Sanofi partner on long-acting mRNA therapies The collaboration will combine Sanofi’s mRNA drug candidates with ScionxBio’s AI-driven TERA platform to develop longer-lasting RNA therapeutics, potentially reducing the need for repeated administration in some medicines

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Analysis
Specifying synthetic peptides: why the impurity profile, not the purity figure, is the specification

Specifying synthetic peptides: why the impurity profile, not the purity figure, is the specification

A single HPLC percentage can’t tell two peptide lots apart. A specification that names impurity classes, sets individual limits and demands mass balance can
Manufacturing
Codis completes demolition and begins construction on PSD-4 expansion at Haverhill

Codis completes demolition and begins construction on PSD-4 expansion at Haverhill

Expansion strengthens Codis’ UK pathway from formulation development through to commercial-scale manufacturing
Analysis
mzio launches first vendor-neutral AI control layer for multimodal mass spectrometry

mzio launches first vendor-neutral AI control layer for multimodal mass spectrometry

mzio GmbH has launched mzassist, a vendor-neutral AI and automation control layer for multimodal mass spectrometry data processing on its open-source mzmine platform
Finance
Panthera expands Glasgow clinical research capacity with new centre at Health Innovation Hub

Panthera expands Glasgow clinical research capacity with new centre at Health Innovation Hub

Purpose-built facility will support Phase II and III trials and broaden participation across Glasgow and the west of Scotland
Finance
Adalvo expands biosimilars portfolio with Romiplostim programme acquisition from Enzene

Adalvo expands biosimilars portfolio with Romiplostim programme acquisition from Enzene

Acquisition accelerates Adalvo’s expansion into complex biologics and strengthens its biosimilars portfolio across development and commercialisation
Drug Delivery
New MHRA research puts needle-free Strep A vaccine within reach

New MHRA research puts needle-free Strep A vaccine within reach

Pioneering study by MHRA scientists advances innovative approach to vaccination and promise of vaccine against Strep A, a major global cause of sore throat, scarlet fever, invasive infections and rheumatic heart disease
Sustainability
CordenPharma achieves EcoVadis gold medal for group-wide sustainability performance

CordenPharma achieves EcoVadis gold medal for group-wide sustainability performance

Group-wide sustainability score of 86/100 places CordenPharma among the top 5% of companies assessed by EcoVadis in the past 12 months
Subscribe now